Claim OwnershipMedtronicTalks
Subscribed: 25Played: 233
Subscribe
© All rights reserved
Description
The MedtronicTalks Podcast Series brings insights, observation and lessons from the leaders of the medtech industry’s single, largest leader. Episodes will center around one of Medtronic’s business units ranging from cardiac care to surgical robotics. We’ll talk with decision-makers who keep Medtronic at the forefront of Medtech. We’ll also speak with regulatory, financial and other operational leaders including the CEO about how Medtronic is preparing for the future.
47 Episodes
Reverse
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management.
Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits.
Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.
Thank you for listening to the Medtronic Podcast.
Subscribe to this podcast on every major podcast platform.
Unlike other businesses at Medtronic, the Mechanical Circulatory Support group isn’t measured by the number of new patients receiving medical devices. Instead, MCS is charged with caring for the nearly 3,000 patients who have already been implanted with Medtronic’s Heartware Ventricular Assist Device (HVAD.) In 2021, Medtronic stopped distributing the HVADs following studies that showed recipients had a higher risk of suffering strokes than those who were implanted with another company’s VAD. But Medtronic’s mission didn’t end with the suspension. In this episode, Raj Thomas, vice president and general manager of MCS, explains how his team continues to support recipients, their caregivers and clinicians to help ensure those heart failure patients can live the fullest lives possible. Thomas details MCS’s steps toward providing support including the organization of a global meeting and the establishment of a patient advisory board.
Thank you to Resonant Link for sponsoring this episode.
Thank you for listening to this episode of the MedtronicTalks Podcast.
Subscribe to this podcast on any major podcast application.
Karen Parkhill assumed the role of chief financial officer at Medtronic six years ago, making her first move into the medical device industry. Over that time, Parkhill has helped oversee many transformations at Medtronic including the reorganization into 20 business units. As CFO, Parkhill also has had a hand in establishing gender equity pay at Medtronic and serves as the Executive Sponsor of the Medtronic PRIDE Employee Resource Group. She’s also active in cultivating and developing a rising number of women executives. In this interview we’ll talk with Karen Parkhill about the progress Medtronic has made in all those efforts and what she expects from the future.
Thank you for listening to the MedtronicTalks Podcast.
Subscribe to this podcast channel on any major podcast player.
Karen Parkhill assumed the role of chief financial officer at Medtronic six years ago, making her first move into the medical device industry. Over that time, Parkhill has helped oversee many transformations at Medtronic including the reorganization into 20 business units. As CFO, Parkhill also has had a hand in establishing gender equity pay at Medtronic and serves as the Executive Sponsor of the Medtronic PRIDE Employee Resource Group. She’s also active in cultivating and developing a rising number of women executives. In this interview, we’ll talk with Karen Parkhill about the progress Medtronic has made in all those efforts and what she expects from the future.
Thank you for listening to the MedtronicTalks Podcast.
Subscribe to this podcast channel on any major podcast application.
Technologies including AI, robotics and customized implants creates new opportunities for Medtronic’s growing Cranial and Spinal Technologies business. In this episode, Skip Kiil, president of the business unit, explains how his group is deploying technology to drive future growth. Kiil, a former professional baseball player before turning to medtech, also shares critical advice to young medical device executives who are looking to gain relevant experience rapidly. This episode is sponsored by Allied Motion Technologies.
Thank you for listening to the MedtronicTalks Podcast.
You can subscribe to this podcast on any major podcast application.
Dan Volz, president of the neurovascular business at Medtronic, lays out the dire facts regarding stroke. Less than 10 percent of the 15 million strokes that occur each year worldwide are treated, and the number of strokes grows by 10% each year. In this episode, we’ll explore Medtronic’s new agreement with Avail Medsystems, which sells access to a network of communication devices that provide audio and video connection to operating rooms. Avail CEO Daniel Hawkins joins in on the conversation explaining how Avail can facilitation collaboration between surgeons, speed training on new life-saving devices, and even help engineers observe procedures so they can develop new critical tools. The pair will discuss how Medtronic is using Avail’s products day-to-day as well as part of the company’s new Co-Lab Platform to help those developing new neurovascular products outside of Medtronic. Thank you to Cretex Medical for sponsoring this episode.
Thank you for listening to the MedtronicTalks Podcast.
You can subscribe to this podcast on any major podcast player.
In this episode, Krista Sugerman, vice President, global marketing & communications at Medtronic’s diabetes business, shares how diabetes has impacted people close to her and why the company is keeping focused on how a diabetes diagnosis can take over someone’s life. The company is developing tools to help patients monitor their disease and developing longer-lasting equipment that could make managing the disease less of a burden for people with diabetes. This episode is sponsored by BMP Medical.
Thanks for listening to the MedtronicTalks podcast.
You can subscribe to this podcast on any major podcast player.
In this episode, Mira Sahney, president of the Pelvic Health business at Medtronic, explains how incontinence is a debilitating condition that needs more attention and treatment. The company’s implantable sacral neuromodulation therapy system, InterStim, gives people more control over their condition, enabling them to engage in regular daily activities. Sahney discusses this and the ongoing testing of an implantable tibial neuromodulation device that could strengthen bladder control. Sahney also shares details on her engineering career, which has led her to start two medtech companies. She also recently received the Ferolyn Powell Leadership Award from Medtech Women.
Thank you for listening to the MedtronicTalks podcast.
Subscribe to this podcast on any major podcast application.
This episode shines a light on lung cancer, a deadly killer that isn’t getting the attention it deserves. Dr. William Mayfield, WellStar Health System medical director and former chief surgical officer, says lung cancer kills thousands of people every day – more than most other cancers combined – but isn’t screened for as aggressively. Drawing motivation from a personal loss to lung cancer, Emily Elswick, vice president in the Office of the CEO and former vice president and general manager of Lung Health and Visualization, says we currently have the tools necessary to expand screening, but we need to find the will.
In this episode, George Murgatroyd, vice president and general manager of digital surgery, explains how the Touch Surgery is deploying the first AI-powered surgical video and analytics platform to help surgeons learn and perfect new techniques.
Murgatroyd, who joined Medtronic in 2020 when it acquired the maker of Touch Surgery, explains why the system can be the missing link to improve surgeon performance and patient outcomes. This episode is sponsored by Dassault Systèmes.
Thank you for listening to the MedtronicTalks podcast.
This podcast is available on any major podcast app.
In this episode of MedtronicTalks we’ll explore the potential behind the Respiratory Intervention’s group McGrath Mac Video Laryngoscope. The device – which is designed to simplify the arduous procedure of intubating a critically ill patient – proved invaluable during the pandemic when hospitals faced a crush of respiratory patients. We’ll speak with Quan Golomb, senior director of global marketing, and Peter Inglis, engineering director, about the devices growing importance in providing critical airflow to critically ill patients in the ICU. Medtronic is advancing the design – which was the first portable video laryngoscope – and finding support from providers and even payers for the device. This podcast episode was sponsored by Freudenberg.
Thanks for listening to the MedtronicTalks Podcast.
Subscribe on all major podcast players.
In this episode, Jason Fontana, vice president coronary and renal denervation marketing and strategy at Medtronic, will walk us through Medtronic’s successful entry into the drug-eluting stent market over a decade ago with the Endeavor DES, the first modular drug-eluting stent. With a focus on healing and deliverability, Medtronic overcome a late-start to become a leader of the pack following the approval of the Resolute Integrity DES. We’ll review Medtronic’s current coronary portfolio including Onyx Frontier DES with a dual flex balloon. Fontana will also explain how new technologies and diagnostic techniques will help it set the pace in the coronary space in the future. Thanks to Delve for sponsoring!
Thank you for listening to the MedtronicTalks Podcast.
In this episode, two senior leaders from Medtronic’s Cardiovascular Diagnostics & Services group share the group’s vision of “turning data into the right therapy.” Sanjiv Arora, vice president of business development and strategy, and Leo Rapallini, vice president of research & development, explain how trail-blazing technologies like the LINQ family of ICMs are a great tool in measuring infrequent – but important - cardiac events. But the company sees an opportunity to employ these tiny implantable data-collection devices to provide data that might enable doctors to predict problems before they come, both in cardiac care and other areas as part of a broader disease management strategy. This episode was sponsored by Isometric.
To listen to the earlier episode featuring Julie Brewer, president, Cardiovascular Diagnostics and Services go here. https://news.medtronic.com/medtronictalks-podcast-julie-brewer
Thank you for listening to the MedtronicTalks Podcast.
Subscribe on all major podcast applications.
In this episode, Dr. Laura Mauri shares the career path that started with an early interest in medicine brought, at least partly, by her mother’s cancer diagnosis. Mauri directed that interest in caring for patients – and an innate ability to keep cool under pressure – to become an interventional cardiologist, a career that led her to appreciate the benefits of new technologies. This interest in new devices drew her to join Medtronic in 2018. This year, she was named senior vice president and chief scientific, medical and regulatory officer. We’ll talk with her about the “good surprises’ she encountered at Medtronic as well as the impact that the pandemic’s fallout will have on clinical trials and clinical workflow going forward. This episode is sponsored by Medmarc insurance Group.
In this episode of the MedtronicTalks Podcast, Mike Hess, vice president of corporate technology and innovation at Medtronic, will introduce listeners to Design for Reliability & Manufacturability, a design framework that equips engineers, designers and others with a set of standards that ensure new devices are designed right from the start. The DRM program has taken on increased importance as Medtronic moved into a new corporate structure with 20 individual business units. In this discussion, Hess will explain how the DRM program instills uniformity across the world’s largest medical device company. This episode is sponsored by Performance Motion Devices.
Greg Smith brought decades of supply chain experience with him when he joined Medtronic last year during the throes of pandemic-induced pressures on supply chain. Over that time, Smith has been working with company leaders and outside suppliers to mitigate the challenges being wrought by the string of global crises. In this episode, we’ll learn how Medtronic is working to build a stronger supply chain that will allow it to build an inventory capable of keeping critical medical devices flowing to customers. This podcast is sponsored by Donatelle.
Ruchika Singhal, president of Medtronic Labs, says she grew up in Medtronic, starting her career as an engineer. But her professional life really began when she took over Medtronic Labs, a non-profit quasi-independent arm with a mission of bringing better healthcare to more people worldwide. In this podcast, Singhal shares her story and identifies the one thing that will help more people living away from big cities and healthcare hubs. “We’re never going to have enough doctors and we’re never going to have enough infrastructure,” Singhal says. “Technology is the solution.” Medtronic Labs is working to leverage technology to help people battle the biggest threat – non communicable diseases like diabetes which can be managed with proper care. This episode is sponsored by AcuityMD. Go to AcuityMD.com for more information.
This episode of MedtronicTalks explores the company’s efforts to flag the multiple sources of healthcare inequity wrought by racial, geographic or economic differences in the U.S. Among the topics discussed, Karen Shehade of Medtronic Americas Region Medical Affairs organization explains how Medtronic leadership is seeking a sustainable and scalable way to make a difference in how people receive correct care more easily. Dr. John de Csepel, Chief Medical Officer and Vice President of Medical Affairs, Americas Region, discusses possible solutions. This episode is sponsored by MTD Micro Molding.
In this episode, Jennifer McVean, MD, medical affairs director at Medtronic’s diabetes business, shares how a devastating childhood diagnosis started her on her mission to help people with diabetes. McVean used that inspiration to push her through medical school and a career in treating children. Now, she’s taking her skills and experience to Medtronic. Hear why she’s excited about the move and grateful to Medtronic technology. SPONSORED BY SUNRISE LABS.
In this episode, Austin L. Chiang, MD, explains why he brought his sizable social media following to Medtronic, where he serves as chief medical officer of the Gastrointestinal business. Chiang says his decision is directly tied to his excitement about Medtronic’s growing suite of GI products including the AI-powered GI Genius and the swallowable PillCam. Chiang explains why he chose to couple the company’s broad platform with his own social media presence to reach more patients who may need treatment of gastrointestinal care. He also gives advice to other physicians who may want to amplify their own voices through social media.
Comments
Download from Google Play
Download from App Store
United States